Scientific Advisory Board

Terry J. Fry, M.D. Faculty and Director of Cancer Immunotherapy, University of Colorado Before joining the Anschutz Medical Campus community, Dr. Fry was a Tenure-Track Investigator at the Pediatric Oncology Branch of the National Cancer Institute. Prior to that, he served as Chief of Blood and Marrow Transplantation at Children’s National Medical Center, a position he…

Scientific Advisory Board

Alex Zukiwski, Ph.D. Oncology clinical development executive Dr. Zukiwski has held many leadership roles in global oncology drug development and has supported the clinical evaluation, regulatory affairs, and registration of many successful therapeutic agents, including Taxotere, Xeloda, Procrit/ Eprex, Velcade, Yondelis, and Doxil in companies such as CASI Pharmaceuticals, Arno Therapeutics, MedImmune, Johnson and Johnson, Centocor…

Scientific Advisory Board

Crystal Mackall, M.D. Professor, Stanford University School of Medicine Crystal Mackall, M.D., is a professor of pediatrics and medicine at Stanford University School of Medicine, where she also leads the Cancer Immunology and Immunotherapy Program and serves as associate director of the Stanford Cancer Institute. Between 1998 and 2016, she was at the National Institutes…

Scientific Advisory Board

Daniel D. Von Hoff, M.D., F.A.C.P. Daniel D. Von Hoff, M.D., F.A.C.P., is currently Physician in Chief, Distinguished Professor Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Senior Consultant, Clinical Investigations for the City of Hope; Chief Scientific Officer for HonorHealth Research Institute; Medical Director of Research, Chief Scientific…

Scientific Advisory Board

Robert F. Siliciano, M.D., Ph.D. Robert F. Siliciano’s childhood love of chemistry was literally fueled by his mother, Ann, an anatomy and physiology professor at Elmira College. “I had a lab in the attic, and my mom would get chemicals for me,” he said. “I had liters of ether and benzene, concentrated hydrochloric acid, toluene.…

Scientific Advisory Board

Cohava Gelber, PhD, MBA Cohava Gelber, PhD, MBA, is an executive with over 25 years of experience in discovery and development of immune therapeutics and diagnostics for cancer, autoimmune disease, allergies and infectious diseases.  Dr. Gelber held various executive positions in academia (Duke University) and biopharmaceutical companies (ImmuLogic Pharmaceutical Corporation, Molecular Discoveries and MannKind Corporation).…

Scientific Advisory Board

Jerome Zack, Ph.D., Professor, David Geffen School of Medicine, UCLA Dr. Jerome Zack is a Professor in the Department of Medicine and Professor and Chair of the Department of Microbiology, Immunology & Molecular Genetics at the David Geffen School of Medicine at UCLA. He joined the UCLA faculty in 1991 and teaches the undergraduate immunology…

Scientific Advisory Board

Paul Volberding, M.D., Professor of Medicine, UCSF School of Medicine Dr. Volberding is a practicing physician, scientist, and global ambassador in the fight against HIV/AIDS. He became involved in the early AIDS epidemic in San Francisco and has worked in clinical trials in HIV-related malignancies, and in the development of antiretroviral therapy. Dr. Volberding is…

Scientific Advisory Board

Steven G. Deeks, M.D., Professor of Medicine in Residence at the UCSF School of Medicine, Faculty Member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital Dr. Deeks has been engaged in HIV research and clinical care since 1993 and is a recognized expert on HIV-associated immune dysfunction…